<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35436862</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>20</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>23</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1471-2415</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>22</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Apr</Month>
              <Day>18</Day>
            </PubDate>
          </JournalIssue>
          <Title>BMC ophthalmology</Title>
          <ISOAbbreviation>BMC Ophthalmol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Demographic and clinical features of pediatric uveitis and scleritis at a tertiary referral center in China.</ArticleTitle>
        <Pagination>
          <StartPage>174</StartPage>
          <MedlinePgn>174</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">174</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1186/s12886-022-02404-z</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">To analyse demographic, clinical features, treatment and therapeutic outcomes of pediatric uveitis and scleritis patients.</AbstractText>
          <AbstractText Label="SUBJECTS" NlmCategory="METHODS">The clinical records of pediatric uveitis and scleritis cases between January 2012 and December 2020 at a tertiary uveitis service center in Tianjin Medical University Eye Hospital (TMUEH) were reviewed.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">In total, 209 patients (337 eyes) were included, 49.3% were male. The median onset age was 9.0 (IQR, 7.0-12.0) years. Chronic uveitis and scleritis accounted for 86.1%. Panuveitis (29.2%), anterior uveitis(29.2%), and intermediate uveitis (22.0%) were the most common presentations. The most common diagnoses were idiopathic (71.3%), JIA (8.1%), and infectious uveitis (4.8%). At baseline, 40.7% patients received oral corticosteroid therapy; during follow-up, corticosteroids (66.0%), disease-modifying antirheumatic drugs (61.2%), and biologic agents (35.4%) were the mainstay. Posterior synechia (26.1%) and cataracts (25.5%) were the most common complications. In acute cases, the median best corrected visual acuity (BCVA) was 0.99 (IQR, 0.5-1.0) at baseline and 0 (IQR, 0-0) at last follow-up; in chronic cases, the median BCVA improved from 1.09 (IQR, 0.5-2.0) to 0.27 (IQR, 0-0.5), with anterior chamber cell grade significantly declining. Ten eyes underwent cataract surgery during regular follow-up and achieved satisfactory long-term visual outcomes and decreased burden of immunosuppressants. The incidence of steroid-induced ocular hypertension was 41.0%, and children with frequent instillation of eyedrops were at high risk.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Most cases were of chronic uveitis and scleritis requiring long-term systemic immunosuppressive therapies in pediatric uveitis and scleritis in China. Good management of complications is important for long-term prognosis.</AbstractText>
          <CopyrightInformation>© 2022. The Author(s).</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Sun</LastName>
            <ForeName>Nan</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, Tianjin, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Chunxi</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, Tianjin, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Linghu</LastName>
            <ForeName>Wenrui</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, Tianjin, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Xiaorong</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, Tianjin, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>Xiaomin</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University Eye Hospital, Tianjin, China. xzhang08@tmu.edu.cn.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>04</Month>
          <Day>18</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>BMC Ophthalmol</MedlineTA>
        <NlmUniqueID>100967802</NlmUniqueID>
        <ISSNLinking>1471-2415</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003710" MajorTopicYN="N">Demography</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015423" MajorTopicYN="Y">Scleritis</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D062606" MajorTopicYN="N">Tertiary Care Centers</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014605" MajorTopicYN="Y">Uveitis</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014792" MajorTopicYN="N">Visual Acuity</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Cataract surgery</Keyword>
        <Keyword MajorTopicYN="N">China</Keyword>
        <Keyword MajorTopicYN="N">Juvenile idiopathic arthritis</Keyword>
        <Keyword MajorTopicYN="N">Pediatric uveitis</Keyword>
        <Keyword MajorTopicYN="N">Scleritis</Keyword>
        <Keyword MajorTopicYN="N">Steroid-induced ocular hypertension</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare that they have no competing interests.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>16</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>13</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>19</Day>
          <Hour>5</Hour>
          <Minute>4</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35436862</ArticleId>
        <ArticleId IdType="pmc">PMC9017000</ArticleId>
        <ArticleId IdType="doi">10.1186/s12886-022-02404-z</ArticleId>
        <ArticleId IdType="pii">10.1186/s12886-022-02404-z</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Chan NS, Choi J, Cheung CMG. Pediatric Uveitis. Asia Pac J Ophthalmol (Phila) 2018;7:192–199.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29682916</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tarsia M, Gaggiano C, Gessaroli E, Grosso S, Tosi GM, Frediani B, et al. Pediatric Scleritis: An Update. 2022;1-10. [Epub ahead of print].</Citation>
        </Reference>
        <Reference>
          <Citation>Waduthantri SMS, Chee SF. Pediatric Uveitis and Scleritis in a Multi-Ethnic Asian Population. 2020;29:7–8.</Citation>
        </Reference>
        <Reference>
          <Citation>Gautam N, Singh R, Agarwal A, Yangzes S, Dogra M, Sharma A, et al.  Pattern of Pediatric Uveitis at a Tertiary Referral Institute in North India. Ocul Immunol Inflamm. 2018;26:379–385. doi: 10.1080/09273948.2016.1239745.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/09273948.2016.1239745</ArticleId>
            <ArticleId IdType="pubmed">27767364</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Keino H, Watanabe T, Taki W, Nakayama M, Nakamura T, Yan K, et al.  Clinical features of uveitis in children and adolescents at a tertiary referral centre in Tokyo. Br J Ophthalmol. 2017;101:406–410. doi: 10.1136/bjophthalmol-2015-308194.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bjophthalmol-2015-308194</ArticleId>
            <ArticleId IdType="pubmed">27335142</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Phatak S, Lowder C, Pavesio C. Controversies in intraocular lens implantation in pediatric uveitis. J Ophthalmic Inflamm Infect. 2016;6:12. doi: 10.1186/s12348-016-0079-y.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12348-016-0079-y</ArticleId>
            <ArticleId IdType="pmc">PMC4805676</ArticleId>
            <ArticleId IdType="pubmed">27009616</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Deschenes J, Murray PI, Rao NA, Nussenblatt RB. International Uveitis Study Group (IUSG): clinical classification of uveitis. Ocul Immunol Inflamm. 2008;16:1–2. doi: 10.1080/09273940801899822.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/09273940801899822</ArticleId>
            <ArticleId IdType="pubmed">18379933</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140:509–16. doi: 10.1016/j.ajo.2005.03.057.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ajo.2005.03.057</ArticleId>
            <ArticleId IdType="pmc">PMC8935739</ArticleId>
            <ArticleId IdType="pubmed">16196117</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Watson PG, Hayreh SS. Scleritis and episcleritis. Br J Ophthalmol. 1976;60:163–191. doi: 10.1136/bjo.60.3.163.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bjo.60.3.163</ArticleId>
            <ArticleId IdType="pmc">PMC1042706</ArticleId>
            <ArticleId IdType="pubmed">1268179</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al.  International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31:390–392.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14760812</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Criteria for diagnosis of Behcet’s disease. International Study Group for Behcet’s Disease. Lancet. 1990;335:1078–80.</Citation>
        </Reference>
        <Reference>
          <Citation>Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes-Garcia L, et al.  Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol. 2001;131:647–652. doi: 10.1016/S0002-9394(01)00925-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0002-9394(01)00925-4</ArticleId>
            <ArticleId IdType="pubmed">11336942</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sen ES, Ramanan AV. Juvenile idiopathic arthritis-associated uveitis. Clinical immunology (Orlando, Fla). 2020;211:108322. doi: 10.1016/j.clim.2019.108322.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.clim.2019.108322</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chan N, Choi J, Cheung C. Pediatric Uveitis. Asia-Pac J Ophthalmol (Philadelphia, Pa) 2018;7:192–199.</Citation>
        </Reference>
        <Reference>
          <Citation>Takase H, Goto H, Namba K, Mizuki N, Okada AA, Ohguro N, et al. Clinical Characteristics, Management, and Factors Associated with Poor Visual Prognosis of Acute Retinal Necrosis. Ocular Immunol Inflammation. 2020:1–6.</Citation>
        </Reference>
        <Reference>
          <Citation>Kesav N, Palestine AG, Kahook MY, Pantcheva MB. Current management of uveitis-associated ocular hypertension and glaucoma. Surv Ophthalmol. 2020;65:397–407. doi: 10.1016/j.survophthal.2019.12.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.survophthal.2019.12.003</ArticleId>
            <ArticleId IdType="pubmed">31816329</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nussenblatt RB, Peterson JS, Foster CS, Rao NA, See RF, Letko E, et al. Initial evaluation of subcutaneous daclizumab treatments for noninfectious uveitis: a multicenter noncomparative interventional case series. Ophthalmology. 2005;112:764-70. </Citation>
        </Reference>
        <Reference>
          <Citation>Armaly MF, Becker B. Intraocular pressure response to topical corticosteroids. Fed Proc. 1965;24:1274–1278.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">5853148</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kaburaki T, Nakahara H, Shirahama S, Suzuki T, Komae K, Aihara M, et al. Pediatric Uveitis in a Referral Center in North Part of Turkey. Ocular Immunol Inflammation. 2020:1–5.</Citation>
        </Reference>
        <Reference>
          <Citation>Kitano M, Tanaka R. Clinical Features and Visual Outcome of Uveitis in Japanese Patients Younger than 18 Years. 2020:1–7.</Citation>
        </Reference>
        <Reference>
          <Citation>Al-Haddad C, BouGhannam A, Abdul Fattah M, Tamim H, El Moussawi Z, Hamam R. Patterns of uveitis in children according to age: comparison of visual outcomes and complications in a tertiary center. BMC Ophthalmol. 2019;19:137. doi: 10.1186/s12886-019-1139-5.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12886-019-1139-5</ArticleId>
            <ArticleId IdType="pmc">PMC6598272</ArticleId>
            <ArticleId IdType="pubmed">31248388</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yalçındağ FN, Güngör SG, Değirmenci MFK. The Clinical Characteristics of Pediatric Non-Infectious Uveitis in Two Tertiary Referral Centers in Turkey. 2019:1–8.</Citation>
        </Reference>
        <Reference>
          <Citation>Sullu Y, Marino A, Weiss PF, Davidson SL, Lerman MA. Symptoms in noninfectious uveitis in a pediatric cohort: Initial presentation versus recurrences. J AAPOS. 2019;23:220.e1–20.e6. doi: 10.1016/j.jaapos.2019.04.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jaapos.2019.04.008</ArticleId>
            <ArticleId IdType="pubmed">31254672</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ferrara M, Eggenschwiler L, Stephenson A, Montieth A, Nakhoul N, Araùjo-Miranda R, et al.  The Challenge of Pediatric Uveitis: Tertiary Referral Center Experience in the United States. Ocul Immunol Inflamm. 2019;27:410–417. doi: 10.1080/09273948.2017.1420202.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/09273948.2017.1420202</ArticleId>
            <ArticleId IdType="pubmed">29333911</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Habot-Wilner Z, Tiosano L, Sanchez JM, Shulman S, Barequet D, Rahat O, et al.  Demographic and Clinical Features of Pediatric Uveitis in Israel. Ocul Immunol Inflamm. 2018;28:43–53. doi: 10.1080/09273948.2018.1535079.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/09273948.2018.1535079</ArticleId>
            <ArticleId IdType="pubmed">30332547</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Abd El Latif E, Fayez Goubran W, El Gemai E, Habib A, Abdelbaki A, Ammar H, et al. Pattern of Childhood Uveitis in Egypt. Ocul immuno inflamm. 2018;27:883–9.</Citation>
        </Reference>
        <Reference>
          <Citation>Souto FMS, Giampietro BV, Takiuti JT, Campos LMA, Hirata CE, Yamamoto JH. Clinical features of paediatric uveitis at a tertiary referral centre in São Paulo, SP, Brazil. Brit J Ophthalmol. 2018;1-5</Citation>
        </Reference>
        <Reference>
          <Citation>Ganesh S, Bala A, Biswas J, Ahmed A, Kempen J. Pattern of Pediatric Uveitis Seen at a Tertiary Referral Center from India. Ocul Immunol Inflamm. 2016;24:402–409. doi: 10.3109/09273948.2015.1012298.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/09273948.2015.1012298</ArticleId>
            <ArticleId IdType="pubmed">26171572</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Consolaro A, Giancane G, Alongi A, van Dijkhuizen E, Aggarwal A, Al-Mayouf S, et al.  Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study. Lancet Child Adolesc Health. 2019;3:255–263. doi: 10.1016/S2352-4642(19)30027-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S2352-4642(19)30027-6</ArticleId>
            <ArticleId IdType="pubmed">30819662</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gao F, Zhao C, Cheng G, Pei M, Liu X, Wang M, et al.  Clinical Patterns of Uveitis in a Tertiary Center in North China. Ocul Immunol Inflamm. 2017;25:S1–s7. doi: 10.3109/09273948.2016.1158279.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3109/09273948.2016.1158279</ArticleId>
            <ArticleId IdType="pubmed">27070829</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guzman J, Oen K, Loughin T. Predicting disease severity and remission in juvenile idiopathic arthritis: are we getting closer? Curr Opin Rheumatol. 2019;31:436–449. doi: 10.1097/BOR.0000000000000620.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/BOR.0000000000000620</ArticleId>
            <ArticleId IdType="pubmed">31085941</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Campanilho-Marques R, Bogas  M, Ramos  F, Santos MJ, Fonseca  JE. Prognostic value of antinuclear antibodies in juvenile idiopathic arthritis and anterior uveitis. Results from a systematic literature review. Acta reumatologica portuguesa. 2014;39:116–22.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24879943</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mahmud SA, Binstadt BA. Autoantibodies in the Pathogenesis, Diagnosis, and Prognosis of Juvenile Idiopathic Arthritis. Front Immunol. 2019;9:3168.</Citation>
        </Reference>
        <Reference>
          <Citation>İnanç M, Şimşek M. Etiological and Clinical Characteristics of HLA-B27-associated Uveitis in a Tertiary Referral Center. Turk J Ophthalmol. 2019;49:10–14.</Citation>
        </Reference>
        <Reference>
          <Citation>Parameswaran P, Lucke M. HLA B27 Syndromes. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright © 2021, StatPearls Publishing LLC., 2021.</Citation>
        </Reference>
        <Reference>
          <Citation>Curragh DS, McAvoy CE, Rooney M, McLoone E. Post-streptococcal uveitis syndrome in a Caucasian population: a case series. Eye (Lond) 2019;33:380–384. doi: 10.1038/s41433-018-0214-0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41433-018-0214-0</ArticleId>
            <ArticleId IdType="pmc">PMC6460694</ArticleId>
            <ArticleId IdType="pubmed">30228367</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Krag S, Larsen D, Albertsen BK, Glerup M. Risk of ocular hypertension in children treated with systemic glucocorticoid. Acta ophthalmologica. 2021.</Citation>
        </Reference>
        <Reference>
          <Citation>Razeghinejad M, Katz L. Steroid-induced iatrogenic glaucoma. Ophthalmic Res. 2012;47:66–80. doi: 10.1159/000328630.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000328630</ArticleId>
            <ArticleId IdType="pubmed">21757964</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clark AF, Wordinger RJ. The role of steroids in outflow resistance. Exp Eye Res. 2009;88:752–759. doi: 10.1016/j.exer.2008.10.004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.exer.2008.10.004</ArticleId>
            <ArticleId IdType="pubmed">18977348</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Angeles-Han S, Rabinovich C. Uveitis in children. Curr Opin Rheumatol. 2016;28:544–549. doi: 10.1097/BOR.0000000000000316.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/BOR.0000000000000316</ArticleId>
            <ArticleId IdType="pmc">PMC4965315</ArticleId>
            <ArticleId IdType="pubmed">27328333</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rohl A, Patnaik JL, Claire Miller D, Lynch AM, Palestine AG. Timing of Quiescence and Uveitis Recurrences After Cataract Surgery in Patients with a History of Uveitis. 2021.</Citation>
        </Reference>
        <Reference>
          <Citation>Ganesh SK, Sudharshan S. Phacoemulsification with intraocular lens implantation in juvenile idiopathic arthritis. Ophthalmic surgery, lasers &amp; imaging: the official journal of the International Society for Imaging in the Eye. 2010;41:104–108. doi: 10.3928/15428877-20091230-19.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3928/15428877-20091230-19</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Foster CS, Barrett F. Cataract development and cataract surgery in patients with juvenile rheumatoid arthritis-associated iridocyclitis. Ophthalmology. 1993;100:809–817. doi: 10.1016/S0161-6420(93)31568-X.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0161-6420(93)31568-X</ArticleId>
            <ArticleId IdType="pubmed">8510892</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guindolet D, Dureau P, Terrada C, Edelson C, Barjol A, Caputo G, et al.  Cataract Surgery with Primary Lens Implantation in Children with Chronic Uveitis. Ocul Immunol Inflamm. 2018;26:298–304. doi: 10.1080/09273948.2016.1213855.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/09273948.2016.1213855</ArticleId>
            <ArticleId IdType="pubmed">27599095</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>O'Rourke M, McCreery K, Kilmartin D, Brosnahan D. Paediatric cataract in the uveitis setting. Eur J Ophthalmol. 2020:1120672120962059.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
